Biotech Ag Bb, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), bought 175,700 shares at $1.51 ($265K) on 2022-10-21, disclosed to the SEC on 2022-10-25.
Open-market purchase of $265k BDTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.51 | 87,850 | $133K | 50.0% |
| 2 | $1.51 | 87,850 | $133K | 50.0% |
| Total | $1.51 avg | 175,700 | $265K | 100% |
| Filing → |
| MGNX | BUY | 2023-10-04 | $669K | — | Filing → |
| MTEM | BUY | 2023-07-19 | $4.0M | — | Filing → |
| BDTX | BUY | 2023-07-03 | $5.0M | — | Filing → |